AIMIA APPOINTS SUZI HERBST AS CHIEF OPERATING OFFICER
TORONTO, Nov. 27, 2023 /CNW/ - Aimia Inc. (TSX: AIM) ("Aimia"), a holding company focused on long-term global investments, announced today that it has appointed Suzanne ("Suzi") Raftery Herbst as Chief Operating Officer, effective immediately.
Ms. Herbst joins Aimia from INNOVATE Corp. (NYSE:VATE) where she most recently served as Chief Operating Officer (COO), playing a key role in operational strategy and execution. INNOVATE is a diversified holding company with a portfolio of subsidiaries employing approximately 3,800 people in a variety of operating segments including infrastructure, life sciences and spectrum.
Phil Mittleman, CEO of Aimia, commented: "Suzi is a seasoned executive with over 23 years of diverse operational experience spanning public and private sectors. Her passion for driving operational efficiencies and building high-performing teams aligns perfectly with our vision for Aimia. We are thrilled to welcome such a dynamic and skilled executive to our team."
Ms. Herbst added: "I am excited to join Aimia at a pivotal moment in its journey. Working alongside Phil and the talented team, I am eager to contribute to the strategic execution that will drive significant value for our employees and investors."
BiographySuzanne Raftery Herbst is the Chief Operating Officer of Aimia Inc. (TSX:AIM). She previously served as Chief Operating Officer of INNOVATE Corp., where she also served as a director on several of INNOVATE Corp.'s subsidiary boards. Prior to joining INNOVATE Corp., Ms. Herbst was the Senior Vice President and Director of Human Resources of Harbinger Capital and Harbinger Group Inc. Before joining Harbinger Capital and Harbinger Group Inc., Ms. Herbst was the Head of Recruiting at Knight Capital Group. Prior to Knight, Ms. Herbst held various positions in the Human Resources and Foreign Exchange Sales departments at Cantor Fitzgerald. Ms. Herbst started her career in the Equity Sales department at Merrill Lynch. She earned a Bachelor of Arts degree in Communications and Studio Art from Marist College.
About AimiaAimia Inc. (TSX: AIM) is a holding company that makes long-term investments in private and public businesses through controlling or minority stakes. We target companies with durable economic advantages evidenced by a track record of substantial free cash flow generation over complete business cycles, strong growth prospects, and guided by strong, experienced management teams. Headquartered in Toronto, Canada, Aimia is positioned to invest in any sector, wherever a suitable opportunity can be identified worldwide. In addition, we seek investments that may efficiently utilize the Company's operating and capital loss carry-forwards to further enhance stakeholder value.
For more information about Aimia, visit www.aimia.com.
SOURCE Aimia Inc.
Ausgewählte Hebelprodukte auf Hemispherx Biopharma
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Hemispherx Biopharma
Der Hebel muss zwischen 2 und 20 liegen
Aktuelle Hemispherx Biopharma Aktie News
Keine Nachrichten im Zeitraum eines Jahres in dieser Kategorie verfügbar.
Eventuell finden Sie Nachrichten, die älter als ein Jahr sind, im Archiv
Hemispherx Biopharma Analysen
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Hemispherx Biopharma nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen
Keine Analysen gefunden.